Pediatric Orthopedic Devices Market By Product Type (Braces & Support Devices, Orthopedic Implants, Pediatric Prosthetics, Spinal Devices, Trauma Devices); By Application (Trauma & Deformities, Cerebral Palsy, Developmental Dysplasia of the Hip [DDH], Clubfoot, Scoliosis); By End User (Pediatric Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers [ASCs], Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Pediatric Orthopedic Devices Market: Transforming Child Musculoskeletal Care Through Advanced Implants, Growth-Friendly Technologies, and Next-Generation Surgical Innovation  – (Updated On: 17-Aug-2026)

The Global Pediatric Orthopedic Devices Market is set to grow at a 10.7% CAGR, rising from USD 4.60 billion in 2025 to USD 9.37 billion by 2032.

 

Pediatric orthopedic devices are designed for children with fractures, congenital deformities, scoliosis, limb-length differences, neuromuscular disorders, and sports injuries. Unlike adult implants, these products must protect growth plates and developing bones while allowing continued skeletal growth.

 

Major device categories include internal fixation systems, such as flexible nails, pediatric plates, screws, and telescopic rods; external fixation systems for limb lengthening and deformity correction; orthotic braces, including AFOs, hip braces, and scoliosis jackets; and growth-modulation systems that gradually guide bone growth.

 

Several important FDA-authorized products are already available. These include OrthoPediatrics' 3P Pediatric Plating Platform and VerteGlide Spinal Growth Guidance System, Zimmer Biomet's The Tether Vertebral Body Tethering System, Arthrex's TightRope fixation devices for pediatric ACL reconstruction, the ApiFix MID-C System, and the MAGEC growing rod system for early-onset scoliosis. Regulatory status varies between FDA clearance and HDE approval.

 

The development pipeline includes OrthoPediatrics' eLLi Growing Rod System, which received FDA Breakthrough Device designation, along with bioresorbable implants, patient-specific 3D surgical guides, virtual surgical planning, and smart internal lengthening technologies.

 

Pediatric fractures represent a major treatment burden. Global data estimated about 31.03 million pediatric fractures in 2021, with an incidence rate of roughly 1,531 per 100,000 children. In the U.S., about 9.5–11.5 fracture-related emergency visits occur per 1,000 children annually, and nearly 1 in 5 children experiences a fracture before adulthood.

 

Pediatric Orthopedic Devices Market By Product Type

Why Are Braces & Support Devices in Demand?

Braces & support devices generate recurring demand because children can require adjustment or replacement as they grow. Major uses include scoliosis, clubfoot, developmental dysplasia of the hip, and selected trauma cases.

Clubfoot is especially relevant to this segment because treatment commonly continues with foot-abduction bracing after initial correction. In 2023, 40,382 children entered Ponseti treatment across reporting low- and middle-income country programs, representing approximately 22% of expected cases in respondent countries.

Scoliosis braces also serve selected growing children before surgical correction becomes necessary, while Pavlik harnesses and abduction braces support early DDH treatment. These growth-dependent treatment pathways give pediatric bracing a more recurring commercial profile than one-time surgical implants.

 

What Is Driving Orthopedic Implant Demand?

Orthopedic implants are primarily procedure-driven products used in pediatric fractures, deformity correction, and reconstruction. The category includes plates, screws, intramedullary nails, guided-growth systems, and related fixation devices.

Complex trauma creates a consistent surgical base, while guided-growth procedures create specialized demand that adult orthopedic implants cannot fully address. Pediatric suppliers therefore compete through implant sizing, procedure-specific systems, and broader portfolios capable of treating multiple stages of skeletal development.

 

Where Are Pediatric Prosthetics Used?

Pediatric prosthetics serve children with congenital limb differences, amputation, severe trauma, and selected developmental conditions. Their commercial pattern differs from permanent adult prostheses because growing children can require repeated resizing, socket changes, component replacement, and eventually new devices.

Demand is closely connected to pediatric rehabilitation, orthotics and prosthetics clinics, and specialist hospitals. Recurring replacement requirements make long-term patient management more important commercially than a single treatment episode.

 

Why Are Spinal Devices a High-Value Product Category?

Pediatric spinal devices can generate high procedure value because a single spinal correction can involve multiple screws, rods, connectors, and related components. Growth-friendly systems add another opportunity in children requiring correction before skeletal maturity. A nationally representative analysis identified 10,081 adolescent idiopathic scoliosis patients undergoing posterior spinal fusion across the 2012 and 2019 KID study years, while AHRQ recorded 12,600 pediatric inpatient spinal-fusion stays across all indications in 2012.

OrthoPediatrics and Globus Medical are among companies with pediatric spinal systems, reflecting continued commercial investment in scoliosis and growing-spine treatment.

 

What Supports Demand for Trauma Devices?

Trauma devices benefit from the large pediatric fracture population and the subset of severe injuries requiring surgical fixation. Products include plates, screws, nails, external fixation systems, and other fracture-stabilization devices. The approximately 31.0 million pediatric fractures recorded globally in 2021 provide a substantial underlying patient base. Although most fractures are treated without implants, unstable and complex injuries create direct surgical-device demand.

Pediatric Orthopedic Devices Market By Application

Trauma & deformities create a broad demand base by combining high-volume injuries with specialized corrective procedures. Fractures can progress from immobilization to internal or external fixation, while angular deformity and limb-length discrepancy can require guided growth, osteotomy, or reconstruction. Growth-dependent deformity is commercially important because treatment can occur in stages. Plates, screws, guided-growth implants, external fixation systems, and limb-lengthening devices allow suppliers to participate in several pediatric reconstruction pathways.

Cerebral palsy creates pediatric orthopedic device demand when musculoskeletal complications progress to bracing, deformity management, hip procedures, or spinal surgery. The commercial opportunity is concentrated in children requiring orthopedic intervention rather than the entire cerebral palsy population. Specialist pediatric centers may use braces, fixation devices, spinal systems, and postoperative support products as part of complex neuromuscular orthopedic care.

Developmental dysplasia of the hip supports both non-surgical bracing and surgical-device demand. The American Academy of Pediatrics has reported clinically evident developmental hip dislocation at approximately 1 per 1,000 births. Applied to the 2024 U.S. birth cohort, this corresponds to approximately 3,629 infants annually. Early cases support demand for Pavlik harnesses and abduction braces. Persistent or later-diagnosed cases can progress to reduction or reconstructive surgery, shifting product demand from orthotic support toward operative devices.

Clubfoot creates recurring demand because treatment commonly involves correction followed by prolonged bracing. Global pooled prevalence has been estimated at approximately 1.18 per 1,000 births. Applied to the global birth cohort used in the analysis, this corresponds to approximately 156,231 affected births annually. The comparable U.S. estimate is approximately 4,681 births per year. Treatment-access expansion is commercially relevant because reported Ponseti enrolment remains considerably below expected incidence in many lower-resource countries.

Scoliosis supports recurring brace use and higher-value spinal implant demand. A 2025 analysis found pooled scoliosis prevalence of 1.65% among children and adolescents, while only a smaller subset progresses into bracing or surgical correction. The ability to supply both specialty bracing and spinal implants can allow manufacturers to participate across multiple treatment stages rather than entering only when surgery is required.

 

Pediatric Orthopedic Devices Market By End User

Pediatric hospitals are central buyers of complex orthopedic implants and instrumentation. They treat severe trauma, spinal deformity, congenital conditions, cerebral palsy-related deformities, and limb-reconstruction cases requiring specialist pediatric surgeons. Hospitals can favor suppliers with broad pediatric portfolios because the same vendor relationship may cover trauma, deformity, spine, sports medicine, bracing, and reconstruction. OrthoPediatrics' portfolio illustrates this multi-category model.

Orthopedic clinics generate demand through fracture follow-up, scoliosis bracing, congenital-condition management, postoperative care, and non-surgical orthopedic treatment. Their product mix tends to include more braces, orthoses, and support products than highly complex hospital surgery. Repeated follow-up during skeletal growth also gives clinics an important role in brace replacement, fitting, and long-term treatment continuity.

ASCs represent an opportunity for selected pediatric orthopedic procedures that do not require complex inpatient care. Relevant cases can include selected trauma procedures, sports medicine, hardware removal, and other elective orthopedic surgery. Procedure efficiency and standardized instrumentation can influence purchasing decisions in this setting, supporting demand for compact systems and procedure-specific kits.

Rehabilitation centers generate stronger demand for prosthetics, orthoses, braces, and supportive products than for implanted devices. Children recovering from trauma, limb reconstruction, neurological conditions, or surgery can require prolonged rehabilitation and repeated device adjustment. Growth makes pediatric prosthetic and orthotic replacement an ongoing requirement, creating recurring interaction between rehabilitation providers and device suppliers.

 

Pediatric Orthopedic Devices Market By Geography

North America has a mature pediatric orthopedic care infrastructure supported by children's hospitals, specialist surgeons, orthopedic practices, and established surgical capacity. The United States is also home to companies including OrthoPediatrics, Globus Medical, Orthofix, DePuy Synthes, and WishBone Medical. Demand is concentrated in pediatric trauma systems, spinal correction, guided growth, specialty bracing, limb reconstruction, and sports procedures.

Europe supports established demand for pediatric implants, braces, spinal systems, and deformity-correction devices through specialist hospitals and national healthcare systems. Scoliosis, trauma, DDH, and congenital deformity treatment provide major device-use pathways. Commercial growth increasingly depends on pediatric-specific product adoption, portfolio upgrades, and replacement of general-purpose orthopedic systems.

Asia-Pacific offers a large long-term patient opportunity as pediatric orthopedic surgical capacity and specialist care expand. Trauma, congenital disorders, clubfoot, scoliosis, and limb deformity create substantial underlying clinical need. Demand varies considerably across countries, making hospital infrastructure, specialist availability, reimbursement, and distribution important factors influencing commercial adoption.

Latin America, the Middle East & Africa offer developing opportunities as access to formal pediatric orthopedic treatment improves. Clubfoot treatment data illustrate the access gap, with many expected cases in lower-resource settings still not entering formal treatment programs. Expansion of specialist services, surgeon training, hospital capacity, and pediatric-device distribution can progressively increase treatment and device utilization.

 

Who Are the Key Companies in the Pediatric Orthopedic Devices Market?

The competitive landscape includes pediatric specialists and diversified orthopedic companies. OrthoPediatrics, Globus Medical, Orthofix Medical, DePuy Synthes/Johnson & Johnson Orthopaedics, and WishBone Medical are established participants across pediatric trauma, spinal systems, deformity correction, limb reconstruction, and bracing.

OrthoPediatrics: The Pure-Play Leader Powering the Pediatric Orthopedic Revolution

is a dedicated pediatric orthopedic company focused exclusively on designing and commercializing implants and instruments for children. Its portfolio spans trauma, deformity correction, scoliosis, and growth-related reconstruction, supported by 87 surgical and specialized bracing systems. The company reported that its products supported approximately 151,000 pediatric patients in 2025, reflecting its strong penetration in pediatric hospitals and surgeon networks.

Globus Medical: Spine Innovation Giant Expanding Into Pediatric Scoliosis & Deformity Care

is a diversified musculoskeletal technology company with a strong spine-focused business that extends into pediatric spinal deformity treatment. Its pediatric exposure is primarily driven through scoliosis and complex spinal correction systems, leveraging its broader adult spine innovation pipeline and surgical platform technologies.

Orthofix Medical: Global Spine & Orthopedics Player Advancing Pediatric Deformity Solutions

operates across spine and orthopedics with a meaningful presence in pediatric deformity and trauma care. The company’s pediatric relevance is concentrated in spinal systems, fracture management solutions, and limb reconstruction technologies, supported by its global distribution and hospital relationships.

DePuy Synthes (Johnson & Johnson MedTech): Global Orthopedic Powerhouse Delivering Pediatric Trauma at Scale

is one of the largest global orthopedic implant providers with a broad portfolio that includes pediatric trauma and reconstructive solutions. Its scale allows it to supply hospitals with comprehensive trauma systems, fixation devices, and surgical instrumentation used across both adult and pediatric orthopedic procedures.

WishBone Medical: Pediatric-First Innovator Redefining Child-Specific Orthopedic Implants

is a dedicated pediatric orthopedic device company specializing in implants and instruments designed specifically for children. The company focuses on trauma, deformity correction, and reconstruction systems tailored to pediatric anatomy, positioning itself as a niche competitor in surgeon-driven pediatric care.

Competition is increasingly based on portfolio breadth. Companies able to supply trauma systems, spinal implants, deformity products, braces, prosthetic-related solutions, and reconstruction systems can participate across more stages of pediatric orthopedic care and deepen relationships with specialist hospitals and surgeons.

 

Pediatric Orthopedic Devices Market Outlook

The Global Pediatric Orthopedic Devices Market is projected to increase from USD 4.60 billion in 2025 to USD 9.37 billion by 2032, growing at a CAGR of 10.7%.

Growth will be supported by the large pediatric fracture burden, increasing use of pediatric-specific implants, recurring bracing requirements, spinal correction procedures, and demand for devices that accommodate skeletal growth. Trauma provides the broadest patient pool, while spinal surgery and complex deformity correction offer higher-value procedure opportunities. Clubfoot, DDH, prosthetics, and specialty bracing add recurring demand throughout childhood.

Manufacturers are increasingly competing through broader pediatric-specific portfolios rather than individual implant families, allowing them to serve several treatment stages through the same hospital, surgeon, and distribution relationships.

 

Pediatric Orthopedic Devices Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 4.60 Billion
Revenue Forecast in 2032	USD 9.37 Billion
Overall Growth Rate	CAGR of 10.7% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Application, By End User, By Geography
By Product Type	Braces & Support Devices, Orthopedic Implants, Pediatric Prosthetics, Spinal Devices, Trauma Devices
By Application	Trauma & Deformities, Cerebral Palsy, Developmental Dysplasia of the Hip [DDH], Clubfoot, Scoliosis
By End User	Pediatric Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers [ASCs], Rehabilitation Centers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Large pediatric fracture and musculoskeletal disorder burden; rising adoption of pediatric-specific implants and growth-friendly orthopedic technologies; recurring demand for braces, orthoses, and prosthetic replacements during skeletal growth; increasing use of spinal correction, guided-growth, deformity-correction, and limb-reconstruction systems
Customization Option	Available upon request